IMNN 8-K 2026-09-29
Imunon, Inc. (IMNN) 8-K dated 2026-09-29 — accession 0001493152-26-044792.
Imunon, Inc. (IMNN) is a biotechnology company listed on US.
Imunon, Inc. filed a 8-K on 2026-09-29. Accession 0001493152-26-044792.
This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. IMNN currently screens at market cap $9.2M.
Not investment advice. The IMNN SEC hub lists recent forms. The stock page is the research view.